Find the latest Pfizer news related to customer service below. We do our best to screen the news provided here for relevance and accuracy, but the links to articles found here are from 3rd parties so occassionally less pertinent materials get published. Please feel free to contact us to report other relevant articles, or to let us know of any material that should be removed.
Poster 2052, presented at The Liver Meeting®, the American Association for the Study of Liver Diseases, Washington, DC, USA, October 20-24, 2017. [8] Safety, Tolerability, and Efficacy of a Combination Treatment of Tropifexor (LJN452) and Cenicriviroc ...
USA Compression Partners (USAC) Reports Q3 Loss, Lags Revenue Estimates. › ‹ You May Like. Top Ranked Value Stocks to Buy for ... Client Support. Contact Us · Share Feedback · Media · Careers · Advertise. Follow Us. Facebook · Twitter · Linkedin · RSS ...
Sales representatives of Pfizer Inc., the world's largest pharmaceutical company, will join Exact Sciences Corp.'s sales representatives in selling the company's non-invasive screening test for colorectal cancer to physicians and health systems under ...
(Reuters) - U.S. drugmaker Pfizer Inc posted a better-than-expected quarterly profit on Tuesday, driven by higher sales of pneumonia vaccine Prevnar and arthritis drug Xeljanz. Continue Reading Below. The company lowered its 2018 revenue expectation to ...
Drugmaker Pfizer Inc. plans to expand manufacturing in Michigan and add 450 jobs under an incentives deal approved Tuesday by the state's economic development arm. Continue Reading Below. The company is expected to spend $465 million building a ...
Amsterdam/Geneva – As the annual global HIV/AIDS conference gets underway in Amsterdam, Médecins Sans Frontières (MSF) is calling out ViiV Healthcare – a division of US and UK pharmaceutical corporations Pfizer and GlaxoSmithKline, plus Japan's ...
Share this article: ZURICH (Reuters) - Novartis (NOVN.S) expects to hit the top of its 2018 sales guidance after a strong second quarter, the CEO said, despite joining Pfizer (PFE.N) in freezing its U.S. drug prices for the rest of the year following ...
Novartis on Wednesday became the second major drug maker to defer price increases for the rest of the year, citing a “dynamic environment” in the U.S. as President Trump attempts to swat away critics and use market-based pressure to bring costs down.
ANALYSIS/OPINION: President Trump renewed his attack on drug manufacturers last week, tweeting, “Pfizer & others should be ashamed that they have raised drug prices for no reason. They are merely taking advantage of the poor & others unable to defend ...
Share this article: NEW YORK/WASHINGTON (Reuters) - U.S. President Donald Trump called Pfizer Chief Executive Ian Read on Tuesday and discussed the company's July 1 price hikes for 10 to 15 minutes, communicating that the increases had ...
Share this article: (Reuters) - U.S. drugmaker Pfizer Inc (PFE.N) said on Wednesday it would split its business into three units and one of them would include a new hospital business segment. The three new units are innovative medicines, established ...
Pfizer Inc. said Tuesday it will defer planned price increases on a slate of its medicines until Jan. 1 or avoid the hikes altogether if President Trump's blueprint for slashing drug prices takes effect, effectively daring the White House to implement ...
Pfizer chief executive Ian Read said late Tuesday that his company would delay increasing the prices of dozens of drug products after President Trump publicly berated the firm one day earlier. The company, in a statement, said the price increases would ...
WASHINGTON — Last week, it was a left-wing political group taking Pfizer Inc. to task for hiking prices on dozens of drugs. On Monday, it was the president, who accused the company of arbitrarily hiking prices and taking advantage of Americans ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Pfizer (PFE), BHP Billiton (BHP) and Facebook (FB). These research reports have been ...
(Reuters) - Pfizer Inc said on Wednesday it planned to invest $600 million in its venture capital fund, a quarter of which would be earmarked for promising research on neuroscience. Continue Reading Below. The new funding will bring total assets ...
Pfizer Inc. has agreed to pay nearly $24 million to settle federal charges that the drug-making giant used a purportedly independent charitable foundation to pay illegal kickbacks to Medicare patients to cover their out-of-pocket drug expenses. The US ...
Pfizer (pfe, -0.25%) reported another quarter of sluggish sales, increasing pressure on the drugmaker to make a deal and replenish its pipeline. The New York-based company said Tuesday it still expects to make a decision on the future of its consumer ...
Pfizer stock fell 4% in early Tuesday trading while Merck stock slipped about 1% after the two drug giants issued their quarterly earnings reports—both of which were somewhat mixed bags despite stronger-than-expected Merck (mrk, +0.05%) profits and a ...
Chuck Landon: C-USA making big moves in hoops · Hepatitis A case confirmed at Ashland McDonald's location · Cabell at 18 Hep A cases · Lost Huntington: Beverly Hills Junior High School · Portion of 5th Avenue closed in Huntington after sinkhole forms ...
The Botox maker, which is slated to report first-quarter results on April 30, could outperform expectations if its aesthetic offerings remain robust "in spite of traditional seasonal weakness," according to Mizuho Securities USA LLC analyst Irina R ...
Arun Chidambaram is the Global Head of Talent Analytics at Pfizer. His main area of focus is building and sustaining analytical capability within HR for large global corporations. Chidambaram has deep experiences in quantitative and visualisation ...
Happy Friday, readers! This is Sy. In recent years, the advent of gene editing and cell-engineering technologies to fight rare diseases, cancer, and a number other serious conditions has taken the biopharma world by storm across the globe. The Food and ...
Dow Jones component Pfizer (PFE) has no interest in acquiring Bristol-Myers Squibb (BMY) — at least not yet, an analyst reportedly said Thursday. X. Error loading player: No playable sources found. The report from Citigroup analyst Andrew Baum sent ...
Cincinnati-based Procter & Gamble is reportedly negotiating with Pfizer Inc. over the sale of the largest U.S. drugmaker's consumer health business. CNBC reported the talks late Tuesday morning, citing unnamed sources. P&G did not immediately respond ...
April 3 (Reuters) - Pfizer Inc said on Tuesday it signed an agreement with Allogene Therapeutics, a company formed by a consortium in which the drugmaker will hold a 25 percent stake, to further develop its allogenic CAR T cell therapy. Continue ...
Dow Jones component Pfizer (PFE) is teaming up with a group of former Kite Pharma executives to take on Gilead Sciences (GILD) and Novartis (NVS) in advanced cancer treatments. X. Error loading player: No playable sources found. Early Tuesday, Pfizer ...
Something Went Wrong! Please contact Customer Service. CLOSE. But details are still thin. Pfizer studied tafamidis in transthyretin cardiomyopathy, which is tied to progressive heart failure. In the study, tafamidis significantly reduced all causes of ...
Please contact Customer Service. CLOSE. Pfizer announced it was considering selling or spinning off its over-the-counter business in October 2017. The unit sells Advil, Centrum and some other big moneymakers. It brought in $3.47 billion in 2017 sales ...
Good morning. When I wrote last month that Facebook would be the biggest loser in the Russian melee, I didn't imagine it would be this bad. But over the last week—while I was enjoying a break from this newsletter—the social network company lost about ...
Happy Monday. I finally got a chance to digest a speech Health & Human Services Secretary Alex Azar gave last week—and there was a lot of meat in it. On the surface, the remarks, delivered to a group of hospital executives last Monday, were about the ...
Erection-friendly red wine has a wide array of nutrition and health-related topics. As many as 42.8 million men are expected to have a decreased interest in sex but an inability to perform. But there are many reasons why a man suffers from erectile ...
NEW YORK/SEOUL— Médecins Sans Frontières (MSF) has filed a legal petition to the Supreme Court of South Korea requesting to review the patent granted to US pharmaceutical corporation Pfizer for its pneumococcal conjugate vaccine (PCV). On 29 ...
Pfizer Inc. reported a surge in profit due to gains from the recently enacted tax law, and the drugmaker said it plans to pay a tax of $15 billion on overseas profits over the next eight years. The company also said it plans to invest about $5 billion ...
Pfizer's fourth-quarter profit soared to $12.27 billion thanks to a huge tax benefit related to the U.S. tax system overhaul. The biggest U.S. drugmaker on Tuesday reported an $11.34 billion benefit, mainly from recalculating deferred tax liabilities ...
Jan 30 (Reuters) - Pfizer Inc forecast 2018 profit and revenue well ahead of analysts' estimates on Tuesday as it expects to benefit from reduced tax rate following the recent changes to the U.S. tax code, and recorded an $11 billion gain from the ...
Pfizer, the U.S. drug giant behind blockbuster treatments like Viagra and the pneumonia vaccine Prevnar, reported fourth quarter 2017 earnings which easily beat Wall Street analyst expectations, including a massive $11 billion boost from President ...
It's going to happen. I have no doubt that Pfizer (NYSE: PFE) will make a significant acquisition this year. After a couple of notable deals in 2016, the big drugmaker was quiet on the merger-and-acquisition front in 2017. Back in November, Pfizer CEO ...
Il colosso farmaceutico americano Pfizer ha deciso di rinunciare agli investimenti nella ricerca di nuovi farmaci per il trattamento delle malattie degenerative come Alzheimer ed il Parkinson. Lo ha annunciato la società, che intende anche licenziare ...
Pfizer, il più grande gruppo farmaceutico al mondo, ha abbandonato la lotta al Parkinson e all'Alzheimer dopo ingenti investimenti che non hanno portato i risultati attesi. È quanto si legge sul Wall Street Journal, che sottolinea come l'annuncio di ...
Pfizer Inc. said Saturday it will stop trying to discover new drugs for Alzheimer's disease and Parkinson's disease, abandoning costly but futile efforts to find effective treatments for the disorders. The cutback will result in layoffs of 300 ...
Sangamo Therapeutics Inc. (SGMO) and Pfizer Inc. (PFE) on Wednesday said they will collaborate to develop a potential gene therapy to treat certain neurodegenerative disorders caused by a gene mutation. The therapy would use zinc finger protein ...
Pfizer Inc. (PFE - Free Report) announced that the FDA has approved a label expansion for its janus kinase (JAK) inhibitor, Xeljanz (tofacitinib), for two doses — 5 mg twice daily and 11 mg once-daily extended-release (XR) formulation. With this ...
Pfizer and Celltrion Inc. launched Inflectra in late 2016. The other Remicade biosimilar, Renflexis, is made by Merck & Co. and Samsung Bioepis Co. Ltd. Pfizer acquired Inflectra when it bought Hospira in 2015. At the time, the drugmaker elected not to ...
Patients with late-stage breast cancer who took Pfizer drug talazoparib had better outcomes three months longer than those who had chemotherapy, according to a new data released Friday, Reuters reported. The results are part of a phase III study of the ...
TRENTON, N.J. – The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence pill gets its first generic ...
Viagra, the well-known erectile dysfunction drug, just got a huge price cut in the U.S. on Monday—thanks to the little blue pill's own manufacturer, pharmaceutical giant Pfizer, which announced last week that it would introduce generic Viagra at a ...
There was no major news in the cancer space this week, except the failure of Pfizer Inc.'s (PFE - Free Report) Bavencio in a gastric cancer study. In a setback to Eisai Co., Ltd. (ESALY - Free Report) , National Institute of Health and Care Excellence ...
The U.K. has become the first place in the world to allow Viagra, U.S. drug giant Pfizer's mega-selling erectile dysfunction treatment, to be sold over the counter and without a prescription. Men seeking out the little blue pill will be able to buy ...
Merck KGaA (MRK.XE) and Pfizer Inc. (PFE) said on Tuesday that avelumab, a cancer immunotherapy, failed to meet the primary objective of a phase 3 trial in patients with certain gastric cancers. The trial assessed avelumab as a third-line treatment in ...
